EFGCP Better Medicines for Children Conference 2022

Event	Conference
Type	Virtual Event
Language	English
Date(s)	18 & 19 Oct. 2022
Day(s)	2 Day(s)
Duration	8 hours/ day

Patronage

European Elections: 6-9 June 2024

The EFGCP “Better Medicines for Children” Conference is an annual flagship event providing a unique opportunity to share best practice, reflect on what has happened since we last met in October 2021, and discuss paediatric updates with a truly global outreach. Despite an ever changing and challenging environment, and the need to meet virtually again, we believe we have been able to organise a dynamic, innovative, and highly engaging conference to inform our delegates of the latest scientific and regulatory developments.

The conference will focus on Global Paediatric Development, its challenges and solutions, and in particular on what has been achieved during the pandemic, and the remaining opportunities and challenges. To this effect, the conference brings together not only distinguished speakers from all around the world but also all the stakeholders involved in paediatric drug development.

Day One, the new elected Chair of the Paediatric Committee (PDCO) at the EMA, will share with us the vision of the PDCO, and regulators and patient representatives will discuss the potential impact on R&D of the implementation of the Clinical Trial Regulation. Stakeholders from around the world while focusing on global alignment will share their view on what can be learnt from paediatric oncology drug development. A panel committed to finding solutions for rare diseases, which present a unique public health challenge, will discuss the latest information on rare diseases. 

Active engagement of conference delegates will be then welcomed in Breakout Sessions to discuss challenges and identify solutions on what could be done to optimise children’s access to new medicines, with a focus on important topics:

1.    How to improve Patient and parents’ involvement in Paediatric research?

2.    Paediatric Lay Summaries

3.    Is it time to prioritise?

At the end of Day 1, a fireside chat will be the opportunity to hear from Dr Koen Norga (former PDCO chair) and Dr Angeliki Siapkara (MHRA and former UK representative on PDCO) about their respective activities and priorities; and also to hear their view and answers to questions raised ahead of the conference. 

Day two will be the opportunity to keep the momentum with experts who joined the 2021 conference. Hot paediatric topics for which multi-stakeholders’ collaboration is more than ever valued to address gaps in scientific knowledge, will explore innovative development avenues that could foster paediatric drug development.

The programme committee looks forward to welcoming you all to the conference for a global educational and networking event that is a unique opportunity to learn from one another, to meet and interact with colleagues from all parts of the world.

We do hope that the 2022 conference will be the last one organised remotely, and 2023 will give us to go back to face-to-face meetings.

For those interested in paediatric drug development, a pre-conference Workshop on  the "Fundamentals of Paediatric Extrapolation" has been set up on October 17. This will be the opportunity to learn from the experts the value of paediatric extrapolation, a topic detailed in the ICH E11 guideline recently released for public consultation. For further details on this pre-conference Workshop, please visit the webpage. 

-> Exclusive Offer: Combine your registration to the pre-conference and to the conference (17, 18 & 19 October 2022), to benefit from exclusive registration rate on both events. Register via this page and select the "Combined Events" registration option.

Thank you for joining us!